<DOC>
	<DOCNO>NCT01145703</DOCNO>
	<brief_summary>The purpose study examine effect Vitamin D supplementation reason ( mechanism ) underlie development type 2 diabetes , metabolic syndrome ( high blood pressure , cholesterol , diabetes , body weight/obesity ) , muscle weakness wasting ( sarcopenia ) , impaired physical function ( poor balance walk ) associate vitamin D deficiency osteopenia/osteoporosis ( bone loss ) . The investigator obtain vitamin D diet sunlight , conversion active vitamin liver kidney promote intestinal absorption calcium regulation bone growth . Therefore , vitamin D deficiency know year lead weaken bone ( osteopenia osteoporosis ) . However , recently , study show vitamin D deficiency associate number disease , include type 2 diabetes , muscle weakness , frailty , metabolic syndrome . It also associate cognitive impairment . Diabetes affect multiple organ system include heart , kidney , musculoskeletal nervous system . The possibility vitamin D deficiency link development type 2 diabetes , metabolic syndrome , muscle weakness wasting ( sarcopenia ) osteopenia/osteoporosis , vitamin D supplementation decrease risk disease , provide relatively easy/accessible inexpensive model preventive therapy decrease incidence disease . In addition , likely genetic ( inherit ) factor play role , relationship gene metabolic abnormality elucidate . Understanding role Vitamin D health allow u translate finding therapy .</brief_summary>
	<brief_title>Vitamin D Supplementation Metabolism Vitamin D Deficient Elderly</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>4085 year age Women must post menopausal ( absence menses 12 month great ) 25hydroxyvitamin D level 20 ng/ml ( 50 nmol/L ) BMI 2545 kg/m2 Non smoker ( non smoking least 12 month : cigarette , cigar , pipe ) Symptomatic heart disease , CAD , CHF , uncontrolled hypertension ( BP 180 mm HG ) unless medically stabilize Currently treat active cancer Type 1 diabetes ; insulin treatment diabetes , poorly control diabetes , HgA1c &gt; 10 % Allergic lidocaine History seizures take antiseizure anti convulsion medication Untreated dyslipidemia National Cholesterol ATPIII 10 year cardiac risk score great 10 % ( www.nhlbi.nih.gov/guidelines/cholesterol/atp3upd04.htm ) Taking oral steroid , warfarin medication interfere fat/muscle metabolism may safely discontinue temporarily specific procedure ( ie 72 hour prior ) Taking medication interfere ability replete Vitamin D Abnormal liver function 2 time normal level Abnormal renal function ( BUN 40 mg/dl , Cr 1.8 mg/dl , CrCl &lt; 60mg/dl ) Hypercalcemia ( Ca &gt; 10.2mg/dl ) Anemia HCT 30 mg/dl , platelets 100,000/cm3 Chronic pulmonary disease ( supplemental O2 ) Other systemic disorder medically treat stable affect ability absorb Vitamin D. MMSE 24 , dementia unstable clinical depression exam Abnormal response exercise test ( ST segment depression great 2mm , chest pain , significant arrhythmia , extreme shortness breath , cyanosis , exercise BP 240/120 mm HG , contraindication exercise ) *requires follow treatment w/ primary MD continue participation study Aerobically train VO2max great 2 SD ageadjusted mean Participant , opinion investigator , unable adhere study protocol due medical orthopedic condition limit ability exercise travel Baltimore VA protocol procedure .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Body Composition</keyword>
	<keyword>Cardiovascular Risk</keyword>
	<keyword>Cognitive Function</keyword>
</DOC>